Current:Home > FinanceFans express outrage at Kelly Monaco's 'General Hospital' exit after 2 decades -Blueprint Money Mastery
Fans express outrage at Kelly Monaco's 'General Hospital' exit after 2 decades
View
Date:2025-04-16 19:26:02
"General Hospital" fans are expressing outrage at Kelly Monaco's exit from the soap opera series.
Monaco, who has starred as Sam McCall in Port Charles on "GH" since 2003, is set to appear as her long-running character for the last time this fall, USA TODAY confirmed Tuesday.
After news of the "Dancing with the Stars" alum's departure from the series surfaced, her supporters took to X and Instagram to show their support for the "GH" star — and fans weren't happy with the decision.
'General Hospital' says'racism has no place' after Tabyana Ali speaks out on online harassment
The two-time Daytime Emmy Award nominee, who first starred as Livvie Locke on the "GH" spinoff series "Port Charles" before joining the flagship show, is a fan favorite. The Pennsylvania native won the first-ever Mirrorball Trophy on season one of "DWTS" alongside her partner Alec Mazo in 2005.
Need a break? Play the USA TODAY Daily Crossword Puzzle.
Later, she returned to the series for the 2012 all-star season with her pro dance partner Val Chmerkovskiy, where she came in third place.
'Kelly did NOTHING to deserve this,' fans say after Kelly Monaco's 'General Hospital' exit
On X, fans slammed Frank Valentini, the executive producer for the ABC soap opera, writing "Imagine if Kelly Monaco is rehired and Frank gets fired. Poetic justice."
One X user wrote: "Kelly Monaco did NOTHING to deserve this and that's all I'm gonna say about it." Another said, "Kelly Monaco has been disrespected by Frank, Varni, & their writers for YEARS. Constantly sidelined & why? Not like Sam (McCall) ever struggled for material."
Another wrote: "The amount of disrespect Kelly Monaco and many of (the) women cast of Port Charles gets is ridiculous. This is awful. Sam is one of the best characters and the disservice the writers have given the character is why this ship is sailing. Make this right!"
veryGood! (481)
Related
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Hi Hi!
- UN Climate Summit Opens with Growing Concern About ‘Laggard’ Countries
- Reena Evers-Everette pays tribute to her mother, Myrlie Evers, in deeply personal letter
- Lori Vallow Found Guilty in Triple Murder Trial
- The 401(k) millionaires club keeps growing. We'll tell you how to join.
- Algae Fuel Inches Toward Price Parity with Oil
- 6 shot in crowded Houston parking lot after disturbance in nightclub, police say
- U.S. Climate Pledge Hangs in the Balance as Court Weighs Clean Power Plan
- Moving abroad can be expensive: These 5 countries will 'pay' you to move there
- Popular COVID FAQs in 2022: Outdoor risks, boosters, 1-way masking, faint test lines
Ranking
- Trump invites nearly all federal workers to quit now, get paid through September
- A Record Number of Scientists Are Running for Congress, and They Get Climate Change
- Despite Electoral Outcomes, Poll Shows Voters Want Clean Economy
- See How Days of Our Lives Honored Deidre Hall During Her 5,000th Episode
- Nevada attorney general revives 2020 fake electors case
- Full transcript of Face the Nation, June 11, 2023
- Tips to keep you and your family safe from the tripledemic during the holidays
- Get 2 MAC Setting Sprays for the Price of 1 and Your Makeup Will Last All Day Long Without Smudging
Recommendation
Current, future North Carolina governor’s challenge of power
Why Maria Menounos Credits Her Late Mom With Helping to Save Her Life
Tots on errands, phone mystery, stinky sweat benefits: Our top non-virus global posts
New York City firefighter dies in drowning while trying to save daughter from rip current at Jersey Shore
Moving abroad can be expensive: These 5 countries will 'pay' you to move there
Shop the Best Lululemon Deals: $78 Tank Tops for $29, $39 Biker Shorts & More
Editors' pick: 8 great global stories from 2022 you might have missed
CRISPR gene-editing may boost cancer immunotherapy, new study finds